5min chapter

PedsCrit cover image

PARDS with Dr. Nadir Yehya and the Cribsiders--Part 3 Adjunctive Treatments, Disparities, and Next Steps

PedsCrit

CHAPTER

The Risk Benefits of ECMO for Refactory ARDS

There's a lot of institutional variability and watch modalities people reach for. But ECMO, just like everything else, you will actually you will get better at it as you do more like surgery. And I think EOLIA was pretty good data. The adult trial had a 30% crossover rate that would have had very significant pvalue if those patients not gone to ECMO in the control arm. Like refractory hypoxamine and hypercarbia does work forrefactory ARDS. In pediatrics they're better than H1N1 because we are now an adult thing. They became an adult thing after NICU and then you pick up on this subsequent thing which is why

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode